Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Kanazawa, Japan Clinical Trials

A listing of Kanazawa, Japan clinical trials actively recruiting patients volunteers.

RESULTS

Found (3) clinical trials

A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy

The drug being tested in this study is called Ixazomib. Ixazomib is being tested to treat people who have RRMM. This study will look at the effectiveness and safety of IRd in participants with RRMM previously receiving an injectable proteasome inhibitor-based therapy. This study consists of two treatment periods, Treatment ...

Phase

0.0 miles

Learn More »

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

2. Clinical hypothesis SGLT2 inhibitor ameliorates fatty liver and obesity. SGLT2 inhibitor stimulates sympathetic activity. SGLT2 inhibitor increases glucagon secretion. SGLT2 inhibitor enhances lipolysis and hepatic glucose production.

Phase

1.0 miles

Learn More »

Sufficient Treatment of Peripheral Intervention by Cilostazol

Recently, Nanto et al. reported that cilostazol effectively prevented restenosis in a retrospective analysis of 121 femoropopliteal artery lesions in percutaneous transluminal angioplasty (PTA) patients who had undergone PTA. In a prospective 3-year follow-up study in 127 patients with similar diseases, the patency rate was significantly higher in the cilostazol ...

Phase

2.91 miles

Learn More »